According to a market report by Lucintel, The future of the global percutaneous mechanical circulatory support device market looks promising with opportunities in the retail, automotive, food & beverage, pharmaceutical, and consumer goods markets. The global percutaneous mechanical circulatory support device market is expected to grow with a CAGR of 9.2% from 2025 to 2031. The major drivers for this market are the increasing cases of cardiac disorders, the rising demand for minimally invasive treatments, and the growing investment in healthcare infrastructure.
A more than 150-page report to understand trends, opportunity and forecast in percutaneous mechanical circulatory support device market to 2031 by type (vertical balers, horizontal balers, two-ram balers, and combination balers), size (small bales, medium bales, and large bales), application (plastic recycling, manufacturing waste management, commercial waste management, construction & demolition waste, and others), end use (retail, automotive, food & beverage, pharmaceuticals, consumer goods, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, vertical baler is expected to witness the highest growth over the forecast period.
Within the end use category, pharmaceutical is expected to witness the highest growth.
Download sample by clicking on percutaneous mechanical circulatory support device market
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Medtronic, Abbott Laboratories, LivaNova, Eurosets, Jarvik Heart, Cardiobridge, Getinge, ABIOMED, Teleflex Incorporated, Berlin Heart are the major suppliers in the percutaneous mechanical circulatory support device market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Packer Bottle Market
Peptide Cancer Vaccine Market
PMI Foam Market
Reteplase Market
Sarcopenia Treatment Market